New patent for Otsuka drug ABILIFY ASIMTUFII
Annual Drug Patent Expirations for ABILIFY+ASIMTUFII Abilify Asimtufii is a drug marketed by Otsuka and is included in one NDA. […]
Source
Annual Drug Patent Expirations for ABILIFY+ASIMTUFII Abilify Asimtufii is a drug marketed by Otsuka and is included in one NDA. […]
Source
Annual Drug Patent Expirations for IBSRELA Ibsrela is a drug marketed by Ardelyx Inc and is included in one NDA. […]
Source
Annual Drug Patent Expirations for XPHOZAH Xphozah is a drug marketed by Ardelyx Inc and is included in one NDA. […]
Source
Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. […]
Source
Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one […]
Source
Annual Drug Patent Expirations for TLANDO Tlando is a drug marketed by Verity and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for QLOSI Qlosi is a drug marketed by Orasis Pharms and is included in one NDA. […]
Source
Annual Drug Patent Expirations for EPHEDRINE+SULFATE Ephedrine Sulfate is a drug marketed by Amneal, Dr Reddys, Endo Operations, Eugia Pharma, […]
Source
New patent for Endo Operations drug EPHEDRINE SULFATE Read Post »
Annual Drug Patent Expirations for ROCKLATAN Rocklatan is a drug marketed by Alcon Labs Inc and is included in one […]
Source